1. Inactivation of Capicua drives cancer metastasis
   Ross A Okimoto et al, 2017, Nature Genetics CrossRef
2. RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma
   Thomas F. Eleveld et al, 2018, Cancer Research CrossRef
3. Making heads or tails – the emergence of capicua (CIC) as an important multifunctional tumour suppressor
   Derek Wong et al, 2020, The Journal of Pathology CrossRef
4. 17q Gain in Neuroblastoma: A Review of Clinical and Biological Implications
   Vid Mlakar et al, 2024, Cancers CrossRef
5. Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification
   Yanna Cao et al, 2017, Oncotarget CrossRef
6. The clinical implementation of copy number detection in the age of next-generation sequencing
   Jayne Y. Hehir-Kwa et al, 2018, Expert Review of Molecular Diagnostics CrossRef
7. Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
   Angela Martinez-Monleon et al, 2022, Scientific Reports CrossRef
8. Immunohistochemistry for ATRX Can Miss ATRX Mutations
   Rose Chami et al, 2019, American Journal of Surgical Pathology CrossRef
9. Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human Prostate Cancer Cell Lines
   Inge Seim et al, 2017, G3 Genes|Genomes|Genetics CrossRef
10. Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
    Jikui Guan et al, 2018, Molecular Case Studies CrossRef
11. Novel Therapeutic Targets in Neuroblastoma
    Prerna Kumar et al, 2019, Neuroblastoma CrossRef
12. High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice
    Jelena Milosevic et al, 2021, Cancers CrossRef
13. TFCP2 Genetic Polymorphism Is Associated with Predisposition to and Transplant Prognosis of Hepatocellular Carcinoma
    Zhikun Liu et al, 2017, Gastroenterology Research and Practice CrossRef
14. Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics
    Michael R. van Gerven et al, 2022, Cancer Science CrossRef